Table 2.
Timing of kidney biopsy, biochemical characteristics, descriptive clinical outcomes, and data availability in native kidney biopsy studies
| Variable | Data available, % (n/N) | |
|---|---|---|
| Timing/type of kidney tissue procurement, % (n/N) | 31.1 (451/1450) | |
| Before serum creatinine peaked | 13.3% (60/451) | |
| After serum creatinine peaked | 86.7% (391/451) | |
| Baseline serum creatinine, mg/dl | 1.3 | 28.1 (407/1450) |
| Peak serum creatinine, mg/dl | 7.19 | 26.7 (387/1450) |
| Last serum creatinine, mg/dl | 1.85 | 25.7 (372/1450) |
| Descriptive clinical outcome, N | 7.5 (109/1450) | |
| Normal kidney function | 44 | |
| Chronic kidney disease | 11 | |
| End-stage renal disease | 40 | |
| Kidney transplant | 1 | |
| Death | 13 |